GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Salarius Pharmaceuticals Inc (FRA:FP1) » Definitions » Price-to-Tangible-Book

Salarius Pharmaceuticals (FRA:FP1) Price-to-Tangible-Book : 0.49 (As of Jun. 06, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Salarius Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-06-06), Salarius Pharmaceuticals's share price is €0.382. Salarius Pharmaceuticals's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was €0.78. Hence, Salarius Pharmaceuticals's Price to Tangible Book Ratio of today is 0.49.

The historical rank and industry rank for Salarius Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

FRA:FP1' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.33   Med: 1.43   Max: 23.5
Current: 0.52

During the past 10 years, Salarius Pharmaceuticals's highest Price to Tangible Book Ratio was 23.50. The lowest was 0.33. And the median was 1.43.

FRA:FP1's Price-to-Tangible-Book is ranked better than
94.5% of 1218 companies
in the Biotechnology industry
Industry Median: 2.825 vs FRA:FP1: 0.52

A closely related ratio is called PB Ratio. As of today, Salarius Pharmaceuticals's share price is €0.382. Salarius Pharmaceuticals's Book Value per Sharefor the quarter that ended in Mar. 2024 was €0.78. Hence, Salarius Pharmaceuticals's P/B Ratio of today is 0.49.


Salarius Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Salarius Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Salarius Pharmaceuticals Price-to-Tangible-Book Chart

Salarius Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.05 1.54 0.73 0.21 0.45

Salarius Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 0.54 0.42 0.45 0.54

Competitive Comparison of Salarius Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, Salarius Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Salarius Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Salarius Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Salarius Pharmaceuticals's Price-to-Tangible-Book falls into.



Salarius Pharmaceuticals Price-to-Tangible-Book Calculation

Salarius Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=0.382/0.778
=0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Salarius Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Salarius Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Salarius Pharmaceuticals (FRA:FP1) Business Description

Traded in Other Exchanges
Address
2450 Holcombe Boulevard, Suite X, Houston, TX, USA, 77021
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The Company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

Salarius Pharmaceuticals (FRA:FP1) Headlines

No Headlines